PREDICTORS OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY
| Autor: | Katelyn Storey, Allison Berg, Raed H. Abdelhadi, Sue Casey, William T. Katsiyiannis, Miranda Kunz, Mosi K. Bennett, Jay Sengupta, Sajya M. Singh, Aaron Thomas |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Fatty replacement Cardiomyopathy medicine.disease Implantable cardioverter-defibrillator Arrhythmogenic right ventricular dysplasia Heart failure Internal medicine cardiovascular system Cardiology Medicine In patient cardiovascular diseases Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of the American College of Cardiology. 73:488 |
| ISSN: | 0735-1097 |
| Popis: | Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by life-threatening ventricular arrhythmias and fibrous or fatty replacement of the myocardium, which can lead to congestive heart failure. Although there are recommendations based on high-risk characteristics, there |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|